Results 141 to 150 of about 579,834 (173)

[Multiple components in Astragalus Injection target CCL2/FOS/PPARG/CXCL8 to suppress cervical cancer progression]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Ma Y, Liu Y, Gao N, Huo Y, Chen M, Li J, Liu J, Zhang M, Yan B, Xu N, Zhao J.   +10 more
europepmc   +1 more source

[Paeoniflorin alleviates cancer-related fatigue during chemotherapy for breast cancer by targeting EZH2/CCNE1 to regulate cell cycle and inflammatory microenvironment]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Li Z, Shi H, Chen J, Liang Y, Wu Y, Zuo Q, Chen Q.   +6 more
europepmc   +1 more source

[Reliability-aware periodicity graph neural network for remote heart rate estimation]. [PDF]

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi
Huang C, Wang Y.
europepmc   +1 more source

[Screening and in vivo validation of key targets for triclosan-associated intervertebral disc degeneration]. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Jiang A, Qin B, Li G, Liu J, Muhammad Y, Ding Z, Sun K, Li J.   +7 more
europepmc   +1 more source

[A method for predicting neurological outcomes after cardiac arrest based on time-frequency domain feature fusion]. [PDF]

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi
Wang X, Yang Y, Wang S, Zhang Y, Gong Y, Yang C.   +5 more
europepmc   +1 more source

[Determination of glufosinate and its metabolite residues in tea by ultra-high performance liquid chromatography-tandem mass spectrometry coupled with precolumn derivatization]. [PDF]

Se Pu
Bi RF, Fu SH, Deng SC, Fu M, Zhang WW, Song YH.   +5 more
europepmc   +1 more source

[Spliceosome defects and neurodevelopmental disorders]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Huang XZ, Chen H, Chen RM.
europepmc   +1 more source

[Preliminary investigation into the mechanisms of thalidomide in inhibiting the malignant transformation of oral leukoplakia]. [PDF]

Hua Xi Kou Qiang Yi Xue Za Zhi
Shang Q, Awuti G, Xu H, Chen Q, Zhao J.
europepmc   +1 more source

[Simultaneous determination of three tryptamines in foods by ultra performance liquid chromatography-tandem mass spectrometry coupled with hydrophilic column separation]. [PDF]

Se Pu
Liao XL, Lin Q, Mei Y, Dou HS, Xu H, He Y, Pan C, Jiang FL.   +7 more
europepmc   +1 more source

[A transition from targeting immune evasion to a multidisciplinary collaborative treatment framework for "homotherapy for heteropathy" in liver metastases]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Zhang Q, Zhang N, Lu YY.
europepmc   +1 more source